Buscar
Congreso SOLACI
HomeInternational CongresseseuroPCR 2014.

euroPCR 2014.

Ver Categoría
Day 2

COMPARE II: biolimus eluting stent with biodegradable polymer versus everolimus at 3 years.

This study randomized 2:1 - 2707 patients to biolimus eluting stent with biodegradable polymer versus everolimus eluting...
solaci -
Ver más
Day 2

BLESS: assessment of platelet reactivity in patients undergoing angioplasty receiving prasugrel.

The aim of this study was to evaluate the modification in residual platelet reactivity by adjusting the...
solaci -
Ver más
Day 2

SORT-OUT V: Similar results of biolimus eluting stent with biodegradable polymer versus sirolimus eluting stent with permanent polymer.

The last results of the SORT OUT V submitted in PCR 2012 showed that biolimus eluting stent...
solaci -
Ver más
Day 2

ACCOAST: pretreatment with prasugrel in non-ST elevation acute coronary syndrome (NSTE-ACS) offers no benefit and increased bleeding

P2Y12 receptor inhibitors are effective in patients experiencing NSTE-ACS, however, the administration timing is not clear. This...
solaci -
Ver más
Day 2

DESSOLVE II: 2-year results show the superiority of the sirolimus eluting stent with fast bio -absorbable polymer.

The aim of this study was to evaluate the performance of the sirolimus eluting stent with bio...
solaci -
Ver más
Day 2

SALUS: New percutaneous valve with promising results regarding aortic regurgitation post implant.

Aortic regurgitation after valve implantation has been shown to be a long -term mortality predictor. The aim...
solaci -
Ver más
Day 2

Safety and efficacy of Cardiobrand device for percutaneous mitral annuloplasty

The Cadiobrand device is implanted through a transseptal approach and makes a reduction in the mitral annulus...
solaci -
Ver más
Day 1

ORBIT II: atherectomy for heavily calcified lesions

The aim of this study was to evaluate the safety and efficacy of coronary orbital atherectomy system...
solaci -
Ver más

SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

Dr. Omar Tupayachi - 0
While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Dr. Andrés Rodríguez - 0
Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Dr. Omar Tupayachi - 0
Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Noticias Institucionales

Check out the best images of the El Salvador 2024 Sessions

solaci - 0
Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

The El Salvador 2024 Sessions are coming soon

solaci - 0
The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

solaci - 0
Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad